Back

Chronic obstructive pulmonary disease and CA125 levels in chronic heart failure (COPA-HF Study)

9 May 2026 (13:30 - 14:15)
Organised by: Logo
Congress Presentation Part of: Heart failure and comorbidities: navigating complex interactions Comorbidities HFA Premium Access Heart Failure 2026 Heart Failure Association (HFA)

About the speaker

Photo
Mr Paul Cevallos

Ramon and Cajal University Hospital, Madrid (Spain)

6 More presentations in this session

Presentation thumbnail
The influence of cardiovascular risk-related comorbidities on the development of dilated cardiomyopathy
Ms N. Beelen (Maastricht, NL)
Abstract Slides Video
Presentation thumbnail
Potential role of CPAP treatment on right ventricular function in patients with heart failure and OSA
Doctor G. Severini (Catanzaro, IT)
Abstract Slides Video
Presentation thumbnail
Continuation versus discontinuation of beta-blockers during hospitalisation for viral pneumonia in patients with COPD and HFrEF
Doctor F. Zhang (Newark, US)
Abstract Slides Video
Presentation thumbnail
Guideline-directed medical therapy use in adults with duchenne muscular dystrophy and heart failure with reduced ejection fraction
Doctor L. Sese (Newcastle-Upon-Tyne, GB)
Abstract Slides Video
Presentation thumbnail
Subclinical myocardial dysfunction in pulmonary tuberculosis as a precursor of heart failure: a strain imaging study
Doctor A. Prasad (Gorakhpur, IN)
Abstract Slides Video

Access the full session

Session thumbnail
Heart failure and comorbidities: navigating complex interactions

The Event

Event poster

Heart Failure 2026

9 May 2026 13:30 CET
You may be interested in
thumbnail
Congress Presentation
Carbohydrate antigen 125 as a biomarker for patients with acute heart failure in a nurse-based heart failure unit in a university hospital
thumbnail
Congress Presentation
Phenotyping of patients with chronic obstructive pulmonary disease and heart failure: data from the swedish heart failure registry
thumbnail
Congress Presentation
The role of CA125 as a congestion biomarker in ischemic heart failure

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources